Management of airway complications following lung transplantation: first interventional bronchoscopy report from Türkiye.


Journal

Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758

Informations de publication

Date de publication:
2024
Historique:
received: 09 12 2023
revised: 23 08 2024
accepted: 23 05 2024
medline: 19 9 2024
pubmed: 19 9 2024
entrez: 19 9 2024
Statut: epublish

Résumé

Lung transplantation is the treatment of last resort for many chronic lung diseases. Airway complications (AC) following lung transplantation, such as bronchial stenosis, dehiscence, malacia, and fistula, account for frequent hospital admissions, additional treatment costs, decreased quality of life, and reduced survival rates. Beyond surgical and medical preventive efforts, interventional bronchoscopy (IB) can be used in the management of these complications. The aim of the study is to evaluate the efficacy of IB on the management of AC following lung transplantation. A retrospective analysis was done using the data of lung transplant patients with AC referred to the interventional pulmonology unit between December 2012 and December 2019. From a total of 116 lung transplants, the data of 14/116 (12%) patients and 14/220 (6.3%) anastomoses in the same lung transplant group with AC requiring IB were analyzed. In these 14 patients, the diseases leading to lung transplantation were interstitial lung diseases (ILD) (50.0%), bronchiectasis (28.6%), pulmonary arterial hypertension (PAH) (7.1%), chronic obstructive pulmonary disease (COPD) (7.1%), and COPD + bronchiectasis (7.1%). Airway stenosis was the most common airway complication, and it developed mostly in the right bronchial system.The 14 patients underwent 27 total sessions of IB with an average of 2-3 per patient. Airway patency was successfully achieved in 74.1% of the procedures. Mechanical dilatation with a balloon and/or a rigid tube was the most preferred procedure (81.5%). Permanent airway patency was achieved in eight (57.4%) patients. No early complications were encountered (0%). The late complication rate was 48.1%. The most frequent late complication was restenosis, which cannot be directly attributed to IB. IB is safe to perform on lung transplant patients with AC. It has low procedural complication rates and can be performed repeatedly. Because of the high rate of restenosis, interventional pulmonologists should find out treatment modalities with lower rates of restenosis.

Sections du résumé

Background/aim UNASSIGNED
Lung transplantation is the treatment of last resort for many chronic lung diseases. Airway complications (AC) following lung transplantation, such as bronchial stenosis, dehiscence, malacia, and fistula, account for frequent hospital admissions, additional treatment costs, decreased quality of life, and reduced survival rates. Beyond surgical and medical preventive efforts, interventional bronchoscopy (IB) can be used in the management of these complications. The aim of the study is to evaluate the efficacy of IB on the management of AC following lung transplantation.
Materials and methods UNASSIGNED
A retrospective analysis was done using the data of lung transplant patients with AC referred to the interventional pulmonology unit between December 2012 and December 2019.
Results UNASSIGNED
From a total of 116 lung transplants, the data of 14/116 (12%) patients and 14/220 (6.3%) anastomoses in the same lung transplant group with AC requiring IB were analyzed. In these 14 patients, the diseases leading to lung transplantation were interstitial lung diseases (ILD) (50.0%), bronchiectasis (28.6%), pulmonary arterial hypertension (PAH) (7.1%), chronic obstructive pulmonary disease (COPD) (7.1%), and COPD + bronchiectasis (7.1%). Airway stenosis was the most common airway complication, and it developed mostly in the right bronchial system.The 14 patients underwent 27 total sessions of IB with an average of 2-3 per patient. Airway patency was successfully achieved in 74.1% of the procedures. Mechanical dilatation with a balloon and/or a rigid tube was the most preferred procedure (81.5%). Permanent airway patency was achieved in eight (57.4%) patients. No early complications were encountered (0%). The late complication rate was 48.1%. The most frequent late complication was restenosis, which cannot be directly attributed to IB.
Conclusion UNASSIGNED
IB is safe to perform on lung transplant patients with AC. It has low procedural complication rates and can be performed repeatedly. Because of the high rate of restenosis, interventional pulmonologists should find out treatment modalities with lower rates of restenosis.

Identifiants

pubmed: 39295601
doi: 10.55730/1300-0144.5830
pii: tjmed-54-04-615
pmc: PMC11407335
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

615-622

Informations de copyright

© TÜBİTAK.

Déclaration de conflit d'intérêts

Conflict of interest: The authors declare that they do not have any disclaimers or conflicts of interest.

Auteurs

Efsun Gonca Uğur Chousein (EG)

Division of Interventional Pulmonology, Department of Pulmonology, Yedikule Chest Diseases and Thoracic SurgeryEducation and Research Hospital, University of Health Sciences, İstanbul, Turkiye.

Demet Turan (D)

Division of Interventional Pulmonology, Department of Pulmonology, Yedikule Chest Diseases and Thoracic SurgeryEducation and Research Hospital, University of Health Sciences, İstanbul, Turkiye.

Mustafa Vayvada (M)

Division of Lung Transplantation, Department of Thoracic Surgery, Kartal Kosuyolu Training and Research Hospital, University of Health Sciences, İstanbul, Turkiye.

Elif Tanriverdi (E)

Division of Interventional Pulmonology, Department of Pulmonology, Yedikule Chest Diseases and Thoracic SurgeryEducation and Research Hospital, University of Health Sciences, İstanbul, Turkiye.

Ahmet Erdal Taşçi (AE)

Division of Lung Transplantation, Department of Thoracic Surgery, Kartal Kosuyolu Training and Research Hospital, University of Health Sciences, İstanbul, Turkiye.

Mehmet Akif Özgül (MA)

Division of Interventional Pulmonology, Department of Pulmonology, Başakşehir Çam and Sakura City Hospital, University of Health Sciences, İstanbul, Turkiye.

Erdoğan Çetinkaya (E)

Division of Interventional Pulmonology, Department of Pulmonology, Yedikule Chest Diseases and Thoracic SurgeryEducation and Research Hospital, University of Health Sciences, İstanbul, Turkiye.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH